4.6 Letter

Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma

Zenon Konteatis et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Multidisciplinary Sciences

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang et al.

NATURE (2009)